---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-099712"
form_type: "8-K"
ticker: "NVCT"
cik: "0001875558"
company_name: "Nuvectis Pharma, Inc."
filed_at: "2026-08-21T20:31:12+00:00"
generated_at: "2026-08-21T20:32:29.272834+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Nuvectis Pharma establishes new $200M ATM offering program with Jefferies

## Summary
- Entered Open Market Sale Agreement with Jefferies LLC on Aug 21, 2026, for up to $200M in common stock.
- Sales made via new Form S-3 shelf registration filed Aug 21, 2026; Jefferies fee up to 3.0% of gross proceeds.
- Prior ATM program terminated July 20, 2026; no further sales under the Feb 13, 2026 prospectus supplement.
- No minimum sales required; proceeds used for general corporate purposes, if any shares are sold.

## SEC filing metadata
- accession: 0001104659-26-099712
- form_type: 8-K
- ticker: NVCT
- cik: 0001875558
- company_name: Nuvectis Pharma, Inc.
- filed_at: 2026-08-21T20:31:12+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1875558/000110465926099712/0001104659-26-099712-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1875558/000110465926099712/tm2623689d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-099712
- JSON: https://secwatch.observer/filing/0001104659-26-099712.json
- Plain text: https://secwatch.observer/filing/0001104659-26-099712.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.